Literature DB >> 5410994

Intermittent high dose oral methotrexate therapy in psoriasis.

H Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5410994     DOI： 10.1111/j.1365-2133.1970.tb02194.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Drug induced bullous eruptions.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

2.  Treatment of arthritis associated with psoriasis.

Authors: 
Journal:  Br Med J       Date:  1978-02-04

3.  The protein binding of methotrexate by the serum of normal subjects.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

4.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

5.  Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1972-03-11

6.  Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides.

Authors:  Debra L Breneman; Timothy J Storer; John C Breneman; Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.